Finance

Lists
Outlook: 36.7% bullish·16.7% bearish
Go to analysis
UNH:NYSE
UnitedHealth Group Inc
USD 376,32
+0,02%
(+0,090) 1D
USD 374,20
-0,56% (-2,12)
Pre-market
Closed: 6 Okt., 16:00:03 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for UNH...
Mkt. cap
331,82 mjd
Avg. vol.
4,77 m
Volume
16,76 k
Dividend
2,47%
Quarterly dividend
USD 2,32
Ex-dividend date
14 Sep. 2026
P/E ratio
24,20
52-wk high
USD 461,62
52-wk low
USD 255,96
EPS
USD 15,55
Beta
0,60
Shares outstanding
897,60 m
No. of employees
390 k
Mkt. cap
331,82 mjd
Avg. vol.
4,77 m
Volume
16,76 k
Dividend
2,47%
Quarterly dividend
USD 2,32
Ex-dividend date
14 Sep. 2026
P/E ratio
24,20
52-wk high
USD 461,62
52-wk low
USD 255,96
EPS
USD 15,55
Beta
0,60
Shares outstanding
897,60 m
No. of employees
390 k
News stories
From web sources and news partners
About UnitedHealth Group Inc
CEOStephen J. Hemsley
Employees390 k
FoundedJan. 1977
Headquarters-
SectorHealth care provider
Analyst ratings
Based on 21 analysts giving stock ratings to UNH in the past 3 months
Strong buy
Buy
17
Hold
4
Sell
0
12-month forecast
Based on 21 Wall Street analysts offering 12 month price targets for UNH in the last 3 months.
Highest
Current USD 376,32
USD 529,00 (+40,57%)
Average
USD 487,22 (+29,47%)
Lowest
USD 430,00 (+14,26%)
Analyst
Recommendation
Action
Price target
Projected
Date
Lance Wilkes
Bernstein
Buy
Maintained
USD 512,00
+36,1%
10/05/2026
Scott Fidel
Goldman Sachs
Buy
Reiterated
USD 490,00
+30,2%
10/02/2026
Stephen Baxter
Wells Fargo
Buy
Maintained
USD 526,00
+39,8%
09/15/2026
Elizabeth Anderson CFA
Evercore ISI
Buy
Maintained
USD 480,00
+27,6%
09/14/2026
A.J. Rice
UBS
Buy
Maintained
USD 490,00
+30,2%
09/14/2026
Andrew Mok CFA
Barclays
Buy
Maintained
USD 441,00
+17,2%
09/10/2026
Hans Engel
Erste Group
Hold
Downgraded
-
-
08/27/2026
George Hill
Deutsche Bank
Hold
Maintained
-
-
08/03/2026
Lisa Gill
J.P. Morgan
Buy
Maintained
USD 516,00
+37,1%
07/21/2026
Ann Hynes
Mizuho Securities
Buy
Maintained
USD 493,00
+31%
07/21/2026
Ryan Langston
TD Cowen
Hold
Maintained
USD 430,00
+14,3%
07/19/2026
Ben Hendrix
RBC Capital
Buy
Reiterated
USD 478,00
+27%
07/16/2026
Erin Wright
Morgan Stanley
Buy
Reiterated
USD 529,00
+40,6%
07/17/2026
Kevin Fischbeck
Bank of America Securities
Buy
Reiterated
USD 512,00
+36,1%
07/17/2026
Whit Mayo
Leerink Partners
Buy
Reiterated
-
-
07/17/2026
David S Macdonald
Truist Financial
Buy
Reiterated
USD 500,00
+32,9%
07/17/2026
David Toung
Argus Research
Buy
Maintained
USD 470,00
+24,9%
07/17/2026
Michael Ha
Robert W. Baird
Hold
Upgraded
USD 453,00
+20,4%
07/17/2026
Michael Wiederhorn
Oppenheimer
Buy
Reiterated
USD 500,00
+32,9%
07/17/2026
Jessica Tassan
Piper Sandler
Buy
Maintained
USD 475,00
+26,2%
07/15/2026
Matthew Gillmor CFA
KeyBanc
Buy
Maintained
USD 475,00
+26,2%
07/14/2026
Sidharth Sahoo
HSBC
Hold
Maintained
USD 380,00
+1%
07/06/2026
Michael Craig Jones
Bank of America Securities
Buy
Reiterated
USD 475,00
+26,2%
06/24/2026
John Ransom
Raymond James
Buy
Maintained
USD 370,00
-1,7%
04/22/2026
David Windley
Jefferies
Buy
Maintained
USD 373,00
-0,9%
04/20/2026
Bram Kaplan
J.P. Morgan
Buy
Maintained
USD 389,00
+3,4%
02/02/2026
Sarah James
Cantor Fitzgerald
Buy
Maintained
USD 440,00
+16,9%
01/28/2026
Next call oor 6 dae
Di. 13 Okt., 14:00
Fiscal period
Q3 2026
EPS / Est. (USD)
- / USD 4,15
Revenue / Est. (USD)
- / 111,49 mjd
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
113,16 mjd
113,61 mjd
111,72 mjd
112,03 mjd
Cost of goods sold
92,52 mjd
94,10 mjd
86,31 mjd
88,73 mjd
Cost of revenue
92,52 mjd
94,10 mjd
86,31 mjd
88,73 mjd
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
15,22 mjd
15,60 mjd
15,39 mjd
14,27 mjd
Operating expense
16,32 mjd
16,71 mjd
16,42 mjd
15,31 mjd
Total operating expenses
108,85 mjd
110,81 mjd
102,73 mjd
104,04 mjd
Operating income
4,32 mjd
2,80 mjd
8,99 mjd
7,99 mjd
Other non operating income
-
-
-
-
EBT including unusual items
3,23 mjd
-720,00 m
7,96 mjd
6,97 mjd
EBT excluding unusual items
3,31 mjd
1,83 mjd
8,04 mjd
7,03 mjd
Income tax expense
686,00 m
-938,00 m
1,48 mjd
1,30 mjd
Effective tax rate
21,24%
130,28%
18,61%
18,63%
Other operating expenses
-
-
-
-
Net income
2,35 mjd
10,00 m
6,28 mjd
5,48 mjd
Net profit margin
2,07%
0,01%
5,62%
4,89%
Earnings per share
2,92
2,11
7,23
6,38
Interest and investment income
-
-
-
-
Interest expense
-1,00 mjd
-974,00 m
-955,00 m
-962,00 m
Net interest expenses
-1,00 mjd
-974,00 m
-955,00 m
-962,00 m
Depreciation and amortization charges
1,10 mjd
1,12 mjd
1,03 mjd
1,04 mjd
EBITDA
5,41 mjd
3,92 mjd
10,02 mjd
9,03 mjd
Gain or loss from assets sale
83,00 m
-784,00 m
72,00 m
61,00 m
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google-programme